208 related articles for article (PubMed ID: 37130999)
1. Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells.
Erzurumlu Y; Catakli D; Dogan HK
J Nat Med; 2023 Jun; 77(3):572-583. PubMed ID: 37130999
[TBL] [Abstract][Full Text] [Related]
2. The Promising Effects of Astaxanthin on Lung Diseases.
Cheng J; Eroglu A
Adv Nutr; 2021 Jun; 12(3):850-864. PubMed ID: 33179051
[TBL] [Abstract][Full Text] [Related]
3. Astaxanthin induces NADPH oxidase activation and receptor‑interacting protein kinase 1‑mediated necroptosis in gastric cancer AGS cells.
Kim S; Lee H; Lim JW; Kim H
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34608499
[TBL] [Abstract][Full Text] [Related]
4. Astaxanthin Inhibits PC-3 Xenograft Prostate Tumor Growth in Nude Mice.
Ni X; Yu H; Wang S; Zhang C; Shen S
Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28282880
[TBL] [Abstract][Full Text] [Related]
5. Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer.
Sun SQ; Zhao YX; Li SY; Qiang JW; Ji YZ
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32784629
[TBL] [Abstract][Full Text] [Related]
6. Anti-androgenic effect of astaxanthin in LNCaP cells is mediated through the aryl hydrocarbon-androgen receptors cross talk.
Montazeri-Najafabady N; Chatrabnous N; Arabnezhad MR; Azarpira N
J Food Biochem; 2021 Apr; 45(4):e13702. PubMed ID: 33694182
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
9. Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications.
Choi CI
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31018521
[TBL] [Abstract][Full Text] [Related]
10. Effects of Isoflavone-Rich NADES Extract of
Semenov AL; Tyndyk ML; Von JD; Ermakova ED; Dorofeeva AA; Tumanyan IA; Radetskaya EA; Yurova MN; Zherebker A; Gorbunov AY; Fedoros EI; Panchenko AV; Anisimov VN
Plants (Basel); 2023 Jan; 12(3):. PubMed ID: 36771648
[TBL] [Abstract][Full Text] [Related]
11. WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.
Zhou Q; Chen X; He H; Peng S; Zhang Y; Zhang J; Cheng L; Liu S; Huang M; Xie R; Lin T; Huang J
Theranostics; 2021; 11(10):4809-4824. PubMed ID: 33754029
[No Abstract] [Full Text] [Related]
12. A preliminary investigation of the enzymatic inhibition of 5alpha-reduction and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and Saw Palmetto lipid extract in vitro.
Anderson ML
J Herb Pharmacother; 2005; 5(1):17-26. PubMed ID: 16093232
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular endothelial growth factor in prostate cancer.
de Brot S; Ntekim A; Cardenas R; James V; Allegrucci C; Heery DM; Bates DO; Ødum N; Persson JL; Mongan NP
Endocr Relat Cancer; 2015 Jun; 22(3):R107-23. PubMed ID: 25870249
[TBL] [Abstract][Full Text] [Related]
14. Astaxanthin decreases the growth-inhibitory dose of cytarabine and inflammatory response in the acute lymphoblastic leukemia cell line NALM-6.
Rastgar A; Sayadi M; Anani-Sarab G; Sajjadi SM
Mol Biol Rep; 2022 Jul; 49(7):6415-6422. PubMed ID: 35441937
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of synergistic induction of apoptosis by the combination therapy with hyperthermia and cisplatin in prostate cancer cells.
Zhang JF; Yan XM; Lan B; Lei YR; Li XH; Gao S; Guo YF; Guo F
Biochem Biophys Res Commun; 2016 Oct; 479(2):159-165. PubMed ID: 27524236
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
17. PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.
Villar J; Quadri HS; Song I; Tomita Y; Tirado OM; Notario V
Cancer Res; 2009 Jan; 69(1):102-10. PubMed ID: 19117992
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of astaxanthin on cisplatin-induced ototoxicity.
Terzi S; Özgür A; Çeliker M; Mercantepe T; Yilmaz A; Tümkaya L; Kaya Ş; Demir E; Dursun E
Adv Clin Exp Med; 2021 Mar; 30(3):315-321. PubMed ID: 33789004
[TBL] [Abstract][Full Text] [Related]
20. Ambra1 induces autophagy and desensitizes human prostate cancer cells to cisplatin.
Liu J; Chen Z; Guo J; Wang L; Liu X
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 29101240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
